News

The findings suggest tetracycline activity may vary depending on drug concentration and local tissue exposure.

This review of the latest dermatological studies includes insights on familial HS comorbidities, localized HA acne patch therapy, profiles of dyshidrotic eczema patients, and more.

Mendelian randomization links specific T‑cell traits to vitiligo risk, spotlighting protective terminal CD4+ cells and harmful CD8+ memory targets.

Microbiome-first biotech in dermatology is shifting from harsh acne treatments to balance-focused solutions, using anti-inflammatory compounds that support healthier skin ecosystems.

Resource-poor environments exist not only globally but also in everyday settings like nursing homes, prisons, foster care, and low-income households.

At EULAR 2026, investigators presented head-to-head data demonstrating significantly higher joint response rates with bimekizumab compared with risankizumab in PsA.

Real clinical case scenarios with progressive diagnostic clues challenge dermatology clinicians to think on their feet, sharpen their diagnostic reasoning, and apply practice-changing takeaways at the point of care.

The patented filaggrin-targeting regimen claims up to 99% atopic dermatitis relief without steroids, boosting hydration and calming itch in adults.

The proposed rule, first introduced in 2015, aimed to prohibit indoor tanning for individuals under 18 because of the known cancer risks associated with UV radiation.

Maryanne Makredes Senna, MD, shares why mineral sunscreens matter for patients with frontal fibrosing alopecia, and why reprimanding sun-seekers may be more detrimental to patient care.

Data presented at SCALE 2026 showed that Ipsen’s investigational recombinant neuroinhibitor achieved significant and sustained improvement in moderate to severe glabellar lines.

Treatment discontinuations due to laboratory abnormalities were uncommon, occurring in 0.7% of patients at week 52 and remaining below 2% through week 140.

Researchers reported that patients with more extensive HS disease involvement experienced significantly greater financial strain.

Phages, or bacteriophages, are viruses that selectively infect bacteria and may offer a new way to treat bacterial skin diseases without antibiotics.

Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series.

Translational Takeaways distills the most clinically relevant findings from emerging dermatology research into clear, practice-focused insights that inform real-world decision-making.

Can "slugging" with petroleum jelly improve skin, or is it just a myth? Read more about the latest social media trend and learn how to counsel your patients in the clinic.

In the Chair puts you in the hot spot, challenging you to navigate complex, real-world cases.

In this first episode, Elizabeth Buzney, MD, explains why EPP patients suffer for years before receiving an accurate diagnosis, and what clinicians need to know about this debilitating rare disease.

Every week, we cut through the noise to bring clinicians the trial results, approvals, and emerging therapies that are actually moving the needle.

Rajani Katta, MD, and Renata Block, DMSCc, MMS, PA-C, explore how gut microbes, fiber, and fermented foods could shape eczema, acne, and rosacea—and why probiotics aren’t one-size-fits-all.

Neal Bhatia, MD, explains why photodynamic therapy's ability to target subclinical damage across the entire field makes it one of dermatology's most powerful chemopreventive tools.

Phase 2 TOIVA data show Palvella's QTORIN rapamycin reduces bleeding and improves quality of life in cutaneous venous malformations, addressing an unmet treatment need.

Biologics and oral JAK inhibitors are now strongly recommended for moderate to severe pediatric atopic dermatitis, signaling a shift toward earlier systemic treatment escalation.

Maryanne Makredes Senna, MD, discusses emerging data suggesting extended-release oral minoxidil tablets may improve efficacy while minimizing cardiovascular adverse effects in patients with androgenetic alopecia.

International experts set new skin care guidance for aesthetic procedures, detailing which actives speed healing, reduce irritation and PIH, and improve results.

Kavita Mariwalla, MD, FAAD, explains why melanoma is rising in young women, how tanning trends and sunscreen myths spread online, and what prevention steps work best in younger patients.

Despite rapid market growth, many regenerative aesthetic products lack the rigorous nonclinical and clinical safety data that regulators typically require.

Dermatology Times' editor in chief highlights essential late-breaker data from AAD 2026, including upadacitinib, rezpegaldesleukin, icotrokinra, zasocitinib, envudeucitinib, sonelokimab, and more.